Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study.
Saved in:
| Title: | Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study. |
|---|---|
| Authors: | Tuli, Gerdi1,2 (AUTHOR) gerdi.tuli@unito.it, Munarin, Jessica1,2 (AUTHOR), Ragazzi, Paola3 (AUTHOR), Biasin, Eleonora2,4 (AUTHOR), Felicetti, Francesco5 (AUTHOR), Mussano, Anna6 (AUTHOR), Vallero, Stefano Gabriele2,4,7 (AUTHOR), Bertin, Daniele2,4,8 (AUTHOR), Peretta, Paola1,3 (AUTHOR), Morana, Giovanni2,7,8 (AUTHOR), Fagioli, Franca2,3,4 (AUTHOR), De Sanctis, Luisa1,2,4 (AUTHOR) |
| Source: | Journal of Clinical Medicine. May2026, Vol. 15 Issue 9, p3472. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20770383 |
|---|---|
| DOI: | 10.3390/jcm15093472 |
